I agree with some earlier posts, although I would say our product is more similar to Tharnos then it is to whatsapp. They have a product being used by millions and have no way of generating cash and RAP is a product in its infancy which will have a method of generating cash yet it still needs contracts and/or users. Again not a down ramp or an up ramp simply my opinion. I think the management we have is spectacular and marketing seems to be one of their strong suits.
Two bits of news published on different news web-pages
Financial News Network & NEWS
http://www.finnewsnetwork.com.au/archives/finance_news_network124527.html
ResApp Health Limited (ASX:RAP) has announced further positive results from an adult clinical study into its sound-based respiratory diagnosis technology.
The company has achieved between 91 to 100 percent accuracy in distinguishing adult patients with varying respiratory diseases from those without, using algorithms built using cough like sounds.
The algorithms out performed experienced clinicians during the study, when it came to detecting lower respiratory tract infection in patients initially diagnosed as clear.
ResApp has also reported its paediatric clinic study is progressing well, with three leading U.S. hospitals confirmed as study sites.
ResApp Health Limited reported a net loss of $3.21 million at 30 June 2016.
http://www.news.com.au/finance/busi...s/news-story/e2f56b49282caa970d8f5ac7e6d22cb4
ResApp Health has received further positive results from its adult clinical study underway at Joondalup Health Campus and the Wesley Hospital.
This additional set of preliminary results again demonstrates high levels of sensitivity, specificity and accuracy on an expanded adult dataset, achieving high levels of accuracy (91%-100%) for distinguishing adult patients with URTI, COPD, asthma or pneumonia from subjects with no discernible respiratory disease.
The study correctly detected lower respiratory tract disease in 84% of adult patients initially diagnosed as clear by experienced clinicians using stethoscopes.